US Stock MarketDetailed Quotes

APVO Aptevo Therapeutics

Watchlist
  • 0.471
  • -0.110-18.93%
Close Jul 18 16:00 ET
  • 0.440
  • -0.031-6.56%
Post 19:59 ET
3.63MMarket Cap-5P/E (TTM)

Aptevo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aptevo Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-9.95

-157.25%
Analyst Rating

No Data

Aptevo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Aptevo Therapeutics Earnings Reports

  • Aptevo Therapeutics | 10-Q: Quarterly report

    May 8 08:33 ET

  • Aptevo Therapeutics | 10-K: Annual report

    Mar 5 08:32 ET

  • Aptevo Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 08:30 ET

  • Aptevo Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 08:30 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+0.92%